renovarobio.com (RENB) Company Sales Revenue

Enochian BioSciences - graphic logo of issuer RENB

Renovaro Inc. is developing personalized vaccines by integrating IT analytics with medicine. High scalability driven by AI algorithms and patents promises significant profit growth. The environmental footprint is minimal due to the absence of manufacturing plants. The company's sales volume trajectory confirms these rates, and 0.00 determines the current status of the parameter, making it possible to distinguish random spikes from a sustainable fundamental trend.

RENB Renovaro: Company Revenue in the range 02/21/2024 - 10/01/2025

Analytical breakdowns for Renovaro Inc. (RENB)

- market price and analyst price targets:
Summary company analysis:RENB, Renovaro Biosciences
Original product of Enochian BioSciences

The commercialization of AI cancer diagnostic platforms directly determines the financial stability of Renovaro Inc. (RENB). This metric, through a daily stream of values, eliminates statistical gaps, reflecting the actual pace of cash inflows within the company's aggregate sales volume. Monitoring this metric allows for an assessment of the effectiveness of the experts hired to monetize R&D developments. Investors should weigh revenue growth rates against the risks of inflated capitalization expectations.

Analysis of competing companies

Company Revenue ONC|Revenue and Sales Volume HALO|RVMD (Revolution Medicines, Inc.) - Company Sales Revenue|Company Revenue Ascentage Pharma Corp AAPG|Company Total Sales Volume CG Oncology, Inc.|URGN - Company Revenue|Bicara Therapeutics Inc. (BCAX) - Company Sales|Personalis Inc (PSNL) - Company Revenue|ERAS - Company Gross Revenue|DCTH (Delcath Systems Inc) - Revenue and Sales Volume|Company Revenue YMAB|Revenue and Sales Volume AURA|Company Revenue CADL (Candel)|Accuray, Inc. - Company Sales|SELLAS Life Sciences Group Inc. - Company Revenue|ACTU: Company Sales|Company Total Revenue Citius Oncology Inc|HURA: Revenue and Sales Volume|TARA: Company Total Sales|FATE (fatetherapeutics.com) - Revenue and Sales Volume|Company Sales Aadi Bioscience Inc (WHWK)|Revenue and Sales Volume TCRX|CSBR - Company Total Revenue|Revenue and Sales Volume XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Company Total Revenue|OSTX: Company Sales|Company Sales Revenue RADX (Radiopharm Theranostics)|Artiva (ARTV) - Company Revenue|ANL: Company Total Sales|VERU (Veru Corporation) - Revenue and Sales Volume|Company Total Revenue Tempest Therapeutics, Inc. TPST|Revenue and Sales Volume XLO|MURA: Company Annual Revenue|Revenue and Sales Volume KAPA (kairospharma.com)|Company Gross Revenue OnKure (OKUR)|CytoMed Therapeutics Ltd - Revenue and Sales Volume|curis.com (CRIS) - Company Sales|Apollomics Corp (APLM) - Company Revenue|Tharimmune - Company Sales Revenue|ADVB (Advanced Biomed Corp) - Revenue and Sales Volume|Company Sales Genprex, Inc (GNPX)|Revenue and Sales Volume CLDI|SBFM: Company Annual Revenue|Revenue and Sales Volume XBIO (xeneticbio.com)|Revenue and Sales Volume Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Revenue and Sales Volume|Company Total Revenue American Oncology Network, Inc.|BGNE: Revenue and Sales Volume|Company Sales checkpointtx.com|Company Revenue Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Company Gross Revenue|Company Revenue Ikena (IKNA)|NTBL - Company Total Revenue|Company Revenue viracta.com VIRX|morphosys.com (MOR) - Company Total Revenue|NAYA Biosciences Inc - Revenue and Sales Volume|AAPGV: Company Revenue